Raras
Buscar doenças, sintomas, genes...
Síndrome Ehlers-Danlos
ORPHA:98249CID-10 · Q79.6CID-11 · LD28.1DOENÇA RARA

As Síndromes de Ehlers-Danlos (SED) são um grupo de doenças hereditárias (que passam de pais para filhos) que afetam o tecido conjuntivo do corpo. Elas têm características clínicas (sintomas) e genéticas (causas nos genes) muito variadas, e são marcadas principalmente por articulações excessivamente flexíveis (que se movem mais do que o normal), pele que estica muito (mais elástica que o comum) e tecidos mais frágeis.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

As Síndromes de Ehlers-Danlos (SED) são um grupo de doenças hereditárias (que passam de pais para filhos) que afetam o tecido conjuntivo do corpo. Elas têm características clínicas (sintomas) e genéticas (causas nos genes) muito variadas, e são marcadas principalmente por articulações excessivamente flexíveis (que se movem mais do que o normal), pele que estica muito (mais elástica que o comum) e tecidos mais frágeis.

Pesquisas ativas
26 ensaios
86 total registrados no ClinicalTrials.gov
Publicações científicas
4.693 artigos
Último publicado: 2026

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
Unknown
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Início
Infancy
+ neonatal
🏥
SUS: Cobertura mínimaScore: 35%
Centros em: PA, PR, SC, RS, ES +10CID-10: Q79.6
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (5)
0202010503
Cariótipo — bandas G, Q ou Rgenetic_test
0202010600
Pesquisa de microdeleções/microduplicações por FISHlab_test
0202010694
Sequenciamento completo do exoma (WES)rehabilitation
0202010260
Dosagem de alfa-fetoproteína
0301070040
Atendimento em reabilitação — doenças raras
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🦴
Ossos e articulações
112 sintomas
😀
Face
39 sintomas
💪
Músculos
34 sintomas
🧬
Pele e cabelo
33 sintomas
👁️
Olhos
31 sintomas
❤️
Coração
30 sintomas

+ 251 sintomas em outras categorias

Características mais comuns

Hálux valgo
Aparência facial progeroide
Torção testicular
Lipodistrofia
Atraso de crescimento
Ausência de prega palmar
657sintomas
Sem dados (657)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 657 características clínicas mais associadas, ordenadas por frequência.

Hálux valgoHallux valgus
Aparência facial progeroideProgeroid facial appearance
Torção testicularTesticular torsion
LipodistrofiaLipodystrophy
Atraso de crescimentoGrowth delay

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico4.693PubMed
Últimos 10 anos200publicações
Pico2025124 papers
Linha do tempo
2026Hoje · 2026🧪 1997Primeiro ensaio clínico📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

23 genes identificados com associação a esta condição. Padrão de herança: Autosomal dominant, Autosomal recessive, X-linked recessive.

COL1A1Collagen alpha-1(I) chainDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Type I collagen is a member of group I collagen (fibrillar forming collagen)

LOCALIZAÇÃO

Secreted, extracellular space, extracellular matrix

VIAS BIOLÓGICAS (10)
MET activates PTK2 signalingDevelopmental Lineage of Pancreatic Ductal CellsAssembly of collagen fibrils and other multimeric structuresECM proteoglycansFibronectin matrix formation
MECANISMO DE DOENÇA

Caffey disease

An autosomal dominant disorder characterized by an infantile episode of massive subperiosteal new bone formation that typically involves the diaphyses of the long bones, mandible, and clavicles. The involved bones may also appear inflamed, with painful swelling and systemic fever often accompanying the illness. The bone changes usually begin before 5 months of age and resolve before 2 years of age.

OUTRAS DOENÇAS (13)
Ehlers-Danlos syndrome type 7Aosteogenesis imperfecta type 3osteogenesis imperfecta type 4osteogenesis imperfecta type 1
HGNC:2197UniProt:P02452
FLNAFilamin-ACandidate gene tested inAltamente restrito
FUNÇÃO

Promotes orthogonal branching of actin filaments and links actin filaments to membrane glycoproteins. Anchors various transmembrane proteins to the actin cytoskeleton and serves as a scaffold for a wide range of cytoplasmic signaling proteins. Interaction with FLNB may allow neuroblast migration from the ventricular zone into the cortical plate. Tethers cell surface-localized furin, modulates its rate of internalization and directs its intracellular trafficking (By similarity). Involved in cilio

LOCALIZAÇÃO

Cytoplasm, cell cortexCytoplasm, cytoskeletonPerikaryonCell projection, growth coneCell projection, podosome

VIAS BIOLÓGICAS (5)
RHO GTPases activate PAKsCell-extracellular matrix interactionsOAS antiviral responseGP1b-IX-V activation signallingPlatelet degranulation
MECANISMO DE DOENÇA

Periventricular nodular heterotopia 1

A developmental disorder characterized by the presence of periventricular nodules of cerebral gray matter, resulting from a failure of neurons to migrate normally from the lateral ventricular proliferative zone, where they are formed, to the cerebral cortex. PVNH1 is an X-linked dominant form. Heterozygous females have normal intelligence but suffer from seizures and various manifestations outside the central nervous system, especially related to the vascular system. Hemizygous affected males die in the prenatal or perinatal period.

EXPRESSÃO TECIDUAL(Ubíquo)
Artéria tibial
4950.9 TPM
Cólon sigmoide
3958.6 TPM
Esôfago - Muscular
3824.4 TPM
Aorta
3732.4 TPM
Esôfago - Junção
3728.0 TPM
OUTRAS DOENÇAS (15)
heterotopia, periventricular, X-linked dominantMelnick-Needles syndromeintestinal pseudoobstruction, neuronal, chronic idiopathic, X-linkedfrontometaphyseal dysplasia 1
HGNC:3754UniProt:P21333
ADAMTSL2ADAMTS-like protein 2Candidate gene tested inRestrito
LOCALIZAÇÃO

Secreted

VIAS BIOLÓGICAS (1)
O-glycosylation of TSR domain-containing proteins
MECANISMO DE DOENÇA

Geleophysic dysplasia 1

An autosomal recessive disorder characterized by severe short stature, short hands and feet, joint limitations, and skin thickening. Radiologic features include delayed bone age, cone-shaped epiphyses, shortened long tubular bones, and ovoid vertebral bodies. Affected individuals have characteristic facial features including a 'happy' face with full cheeks, shortened nose, hypertelorism, long and flat philtrum, and thin upper lip. Other distinctive features include progressive cardiac valvular thickening often leading to an early death, toe walking, tracheal stenosis, respiratory insufficiency, and lysosomal-like storage vacuoles in various tissues.

INTERAÇÕES PROTEICAS (3)
OUTRAS DOENÇAS (3)
geleophysic dysplasia 1geleophysic dysplasiaEhlers-Danlos syndrome, dermatosparaxis type
HGNC:14631UniProt:Q86TH1
PRDM5PR domain zinc finger protein 5Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Sequence-specific DNA-binding transcription factor. Represses transcription at least in part by recruitment of the histone methyltransferase EHMT2/G9A and histone deacetylases such as HDAC1. Regulates hematopoiesis-associated protein-coding and microRNA (miRNA) genes. May regulate the expression of proteins involved in extracellular matrix development and maintenance, including fibrillar collagens, such as COL4A1 and COL11A1, connective tissue components, such as HAPLN1, and molecules regulating

LOCALIZAÇÃO

Nucleus

MECANISMO DE DOENÇA

Brittle cornea syndrome 2

A disorder characterized by extreme corneal thinning resulting in corneal rupture after minor trauma, blue sclerae, keratoconus or keratoglobus, hyperelasticity of the skin, and hypermobile joints.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
11.3 TPM
Cervix Ectocervix
8.1 TPM
Útero
7.8 TPM
Cervix Endocervix
7.8 TPM
Fallopian Tube
7.1 TPM
OUTRAS DOENÇAS (2)
brittle cornea syndrome 2brittle cornea syndrome
HGNC:9349UniProt:Q9NQX1
ZNF469Zinc finger protein 469Disease-causing germline mutation(s) inModerado
FUNÇÃO

May be involved in transcriptional regulation

LOCALIZAÇÃO

Nucleus

MECANISMO DE DOENÇA

Brittle cornea syndrome 1

An autosomal recessive disorder characterized by extreme corneal thinning resulting in corneal rupture after minor trauma, blue sclerae, keratoconus or keratoglobus, hyperelasticity of the skin, and hypermobility of the joints. It shares some features with, but is much less severe than, the ocular form of Ehlers-Danlos syndrome (EDS6).

EXPRESSÃO TECIDUAL(Tecido-específico)
Fibroblastos
7.3 TPM
Ovário
4.2 TPM
Cervix Endocervix
2.3 TPM
Útero
2.2 TPM
Cervix Ectocervix
1.9 TPM
INTERAÇÕES PROTEICAS (3)
OUTRAS DOENÇAS (2)
brittle cornea syndrome 1brittle cornea syndrome
HGNC:23216UniProt:Q96JG9
DSEDermatan-sulfate epimeraseDisease-causing germline mutation(s) inRestrito
FUNÇÃO

Converts D-glucuronic acid to L-iduronic acid (IdoUA) residues. Plays an important role in the biosynthesis of the glycosaminoglycan/mucopolysaccharide dermatan sulfate

LOCALIZAÇÃO

Endoplasmic reticulum membraneGolgi apparatus membraneCytoplasmic vesicle membraneMicrosome membrane

VIAS BIOLÓGICAS (1)
DS-GAG biosynthesis
MECANISMO DE DOENÇA

Ehlers-Danlos syndrome, musculocontractural type 2

A form of Ehlers-Danlos syndrome characterized by progressive multisystem manifestations, including joint dislocations and deformities, skin hyperextensibility, skin bruisability and fragility with recurrent large subcutaneous hematomas, cardiac valvular, respiratory, gastrointestinal, and ophthalmologic complications. Motor developmental delay is associated with muscle hypoplasia, muscle weakness, and an abnormal muscle fiber pattern in histology in adulthood.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
45.3 TPM
Nervo tibial
27.5 TPM
Tecido adiposo
25.0 TPM
Adipose Visceral Omentum
22.4 TPM
Linfócitos
19.8 TPM
INTERAÇÕES PROTEICAS (4)
OUTRAS DOENÇAS (2)
Ehlers-Danlos syndrome, musculocontractural type 2Ehlers-Danlos syndrome, musculocontractural type
HGNC:21144UniProt:Q9UL01
ADAMTS2A disintegrin and metalloproteinase with thrombospondin motifs 2Disease-causing germline mutation(s) inRestrito
FUNÇÃO

Cleaves the propeptides of type I and II collagen prior to fibril assembly (By similarity). Does not act on type III collagen (By similarity). Cleaves lysyl oxidase LOX at a site downstream of its propeptide cleavage site to produce a short LOX form with reduced collagen-binding activity (PubMed:31152061)

LOCALIZAÇÃO

Secreted, extracellular space, extracellular matrix

VIAS BIOLÓGICAS (1)
Collagen biosynthesis and modifying enzymes
MECANISMO DE DOENÇA

Ehlers-Danlos syndrome, dermatosparaxis type

A form of Ehlers-Danlos syndrome, a group of connective tissue disorders characterized by skin hyperextensibility, articular hypermobility, and tissue fragility. EDSDERMS is an autosomal recessive form characterized by extreme skin fragility and easy bruising, large fontanels, blue sclerae, puffy eyelids, micrognathia, umbilical hernia, and short fingers. Joint hypermobility becomes more important with age.

OUTRAS DOENÇAS (1)
Ehlers-Danlos syndrome, dermatosparaxis type
HGNC:218UniProt:O95450
COL5A1Collagen alpha-1(V) chainDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Type V collagen is a member of group I collagen (fibrillar forming collagen). It is a minor connective tissue component of nearly ubiquitous distribution. Type V collagen binds to DNA, heparan sulfate, thrombospondin, heparin, and insulin

LOCALIZAÇÃO

Secreted, extracellular space, extracellular matrix

VIAS BIOLÓGICAS (1)
Collagen degradation
MECANISMO DE DOENÇA

Ehlers-Danlos syndrome, classic type, 1

A form of Ehlers-Danlos syndrome, a group of connective tissue disorders characterized by skin hyperextensibility, articular hypermobility, and tissue fragility. The main features of classic Ehlers-Danlos syndrome are joint hypermobility and dislocation, and fragile, bruisable skin. EDSCL1 inheritance is autosomal dominant.

OUTRAS DOENÇAS (3)
fibromuscular dysplasia, multifocalEhlers-Danlos syndrome, classic type, 1Ehlers-Danlos syndrome, classic type
HGNC:2209UniProt:P20908
COL12A1Collagen alpha-1(XII) chainDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Type XII collagen interacts with type I collagen-containing fibrils, the COL1 domain could be associated with the surface of the fibrils, and the COL2 and NC3 domains may be localized in the perifibrillar matrix

LOCALIZAÇÃO

Secreted, extracellular space, extracellular matrix

VIAS BIOLÓGICAS (3)
Collagen degradationAssembly of collagen fibrils and other multimeric structuresCollagen biosynthesis and modifying enzymes
MECANISMO DE DOENÇA

Ullrich congenital muscular dystrophy 2

A form of Ullrich congenital muscular dystrophy, a disease characterized by generalized muscle weakness and striking hypermobility of distal joints in conjunction with variable contractures of more proximal joints and normal intelligence. Additional findings may include kyphoscoliosis, protruded calcanei, and follicular hyperkeratosis (rough skin). More severely affected patients manifest at birth and never achieve independent ambulation, while patients with milder phenotypes might maintain ambulation into adulthood. UCMD2 is a severe, autosomal recessive form with onset at birth.

OUTRAS DOENÇAS (4)
Ullrich congenital muscular dystrophy 2Bethlem myopathy 2Bethlem myopathyUllrich congenital muscular dystrophy
HGNC:2188UniProt:Q99715
THBS2Thrombospondin-2Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Adhesive glycoprotein that mediates cell-to-cell and cell-to-matrix interactions. Ligand for CD36 mediating antiangiogenic properties

LOCALIZAÇÃO

VIAS BIOLÓGICAS (1)
Signaling by PDGF
MECANISMO DE DOENÇA

Intervertebral disc disease

A common musculo-skeletal disorder caused by degeneration of intervertebral disks of the lumbar spine. It results in low-back pain and unilateral leg pain.

EXPRESSÃO TECIDUAL(Ubíquo)
Aorta
511.2 TPM
Artéria coronária
430.7 TPM
Artéria tibial
135.6 TPM
Cervix Ectocervix
134.3 TPM
Cervix Endocervix
112.0 TPM
OUTRAS DOENÇAS (2)
Ehlers-Danlos syndrome, classic-like, 3intervertebral disk degenerative disorder
HGNC:HGNC:11786UniProt:P35442
COL3A1Collagen alpha-1(III) chainDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Collagen type III occurs in most soft connective tissues along with type I collagen. Involved in regulation of cortical development. Is the major ligand of ADGRG1 in the developing brain and binding to ADGRG1 inhibits neuronal migration and activates the RhoA pathway by coupling ADGRG1 to GNA13 and possibly GNA12

LOCALIZAÇÃO

Secreted, extracellular space, extracellular matrix

VIAS BIOLÓGICAS (10)
Integrin cell surface interactionsMET activates PTK2 signalingDevelopmental Lineage of Pancreatic Ductal CellsAssembly of collagen fibrils and other multimeric structuresSignaling by PDGF
MECANISMO DE DOENÇA

Ehlers-Danlos syndrome, vascular type

A severe form of Ehlers-Danlos syndrome, a group of connective tissue disorders characterized by skin hyperextensibility, articular hypermobility, and tissue fragility. EDSVASC is an autosomal dominant disease characterized by joint and dermal manifestations as in other forms of the syndrome, and by proneness to spontaneous rupture of bowel and large arteries. The vascular complications may affect all anatomical areas.

OUTRAS DOENÇAS (6)
polymicrogyria with or without vascular-type Ehlers-Danlos syndromeautosomal dominant Ehlers-Danlos syndrome, vascular typeintracranial berry aneurysmfamilial abdominal aortic aneurysm
HGNC:2201UniProt:P02461
B3GALT6Beta-1,3-galactosyltransferase 6Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Beta-1,3-galactosyltransferase that transfers galactose from UDP-galactose to substrates with a terminal beta-linked galactose residue. Has a preference for galactose-beta-1,4-xylose that is found in the linker region of glycosaminoglycans, such as heparan sulfate and chondroitin sulfate. Has no activity towards substrates with terminal glucosamine or galactosamine residues

LOCALIZAÇÃO

Golgi apparatus, Golgi stack membrane

VIAS BIOLÓGICAS (1)
Glycosaminoglycan-protein linkage region biosynthesis
MECANISMO DE DOENÇA

Ehlers-Danlos syndrome, spondylodysplastic type, 2

A form of Ehlers-Danlos syndrome, a group of connective tissue disorders characterized by skin hyperextensibility, articular hypermobility, and tissue fragility. EDSSPD2 is an autosomal recessive form characterized by an aged appearance, developmental delay, short stature, craniofacial disproportion, generalized osteopenia, defective wound healing, hypermobile joints, hypotonic muscles, and loose but elastic skin.

OUTRAS DOENÇAS (3)
spondyloepimetaphyseal dysplasia with joint laxity, type 1, with or without fracturesEhlers-Danlos syndrome, spondylodysplastic type, 2Al-Gazali syndrome
HGNC:17978UniProt:Q96L58
CHST14Carbohydrate sulfotransferase 14Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Catalyzes the transfer of sulfate to position 4 of the N-acetylgalactosamine (GalNAc) residue of dermatan sulfate. Plays a pivotal role in the formation of 4-0-sulfated IdoA blocks in dermatan sulfate. Transfers sulfate to the C-4 hydroxyl of beta1,4-linked GalNAc that is substituted with an alpha-linked iduronic acid (IdoUA) at the C-3 hydroxyl. Transfers sulfate more efficiently to GalNAc residues in -IdoUA-GalNAc-IdoUA- than in -GlcUA-GalNAc-GlcUA-sequences. Has preference for partially desul

LOCALIZAÇÃO

Golgi apparatus membrane

VIAS BIOLÓGICAS (1)
DS-GAG biosynthesis
MECANISMO DE DOENÇA

Ehlers-Danlos syndrome, musculocontractural type 1

A form of Ehlers-Danlos syndrome characterized by distinctive craniofacial dysmorphism, congenital contractures of thumbs and fingers, clubfeet, severe kyphoscoliosis, muscular hypotonia, hyperextensible thin skin with easy bruisability and atrophic scarring, wrinkled palms, joint hypermobility, and ocular involvement.

OUTRAS DOENÇAS (2)
Ehlers-Danlos syndrome, musculocontractural type 1Ehlers-Danlos syndrome, musculocontractural type
HGNC:24464UniProt:Q8NCH0
COL5A2Collagen alpha-2(V) chainDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Type V collagen is a member of group I collagen (fibrillar forming collagen). It is a minor connective tissue component of nearly ubiquitous distribution. Type V collagen binds to DNA, heparan sulfate, thrombospondin, heparin, and insulin. Type V collagen is a key determinant in the assembly of tissue-specific matrices (By similarity)

LOCALIZAÇÃO

Secreted, extracellular space, extracellular matrix

VIAS BIOLÓGICAS (1)
Collagen degradation
MECANISMO DE DOENÇA

Ehlers-Danlos syndrome, classic type, 2

A form of Ehlers-Danlos syndrome, a group of connective tissue disorders characterized by skin hyperextensibility, articular hypermobility, and tissue fragility. The main features of classic Ehlers-Danlos syndrome are joint hypermobility and dislocation, and fragile, bruisable skin. EDSCL2 inheritance is autosomal dominant.

OUTRAS DOENÇAS (2)
Ehlers-Danlos syndrome, classic type, 2Ehlers-Danlos syndrome, classic type
HGNC:2210UniProt:P05997
PLOD1Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Part of a complex composed of PLOD1, P3H3 and P3H4 that catalyzes hydroxylation of lysine residues in collagen alpha chains and is required for normal assembly and cross-linkling of collagen fibrils (By similarity). Forms hydroxylysine residues in -Xaa-Lys-Gly- sequences in collagens (PubMed:10686424, PubMed:15854030, PubMed:8621606). These hydroxylysines serve as sites of attachment for carbohydrate units and are essential for the stability of the intermolecular collagen cross-links (Probable)

LOCALIZAÇÃO

Rough endoplasmic reticulum membrane

VIAS BIOLÓGICAS (1)
Collagen biosynthesis and modifying enzymes
MECANISMO DE DOENÇA

Ehlers-Danlos syndrome, kyphoscoliotic type, 1

A form of Ehlers-Danlos syndrome, a group of connective tissue disorders characterized by skin hyperextensibility, articular hypermobility, and tissue fragility. EDSKSCL1 is an autosomal recessive form characterized by severe muscle hypotonia at birth, generalized joint laxity, scoliosis at birth, and scleral fragility and rupture of the ocular globe.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
314.9 TPM
Útero
113.2 TPM
Aorta
108.4 TPM
Cervix Endocervix
107.1 TPM
Ovário
92.3 TPM
OUTRAS DOENÇAS (1)
Ehlers-Danlos syndrome, kyphoscoliotic type 1
HGNC:9081UniProt:Q02809
SLC39A13Zinc transporter ZIP13Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Functions as a zinc transporter transporting Zn(2+) from the Golgi apparatus to the cytosol and thus influences the zinc level at least in areas of the cytosol (PubMed:21917916, PubMed:23213233). May regulate beige adipocyte differentiation (By similarity)

LOCALIZAÇÃO

Golgi apparatus membraneCytoplasmic vesicle membraneEndoplasmic reticulum membrane

MECANISMO DE DOENÇA

Ehlers-Danlos syndrome, spondylodysplastic type, 3

A form of Ehlers-Danlos syndrome, a group of connective tissue disorders characterized by skin hyperextensibility, articular hypermobility, and tissue fragility. EDSSPD3 is an autosomal recessive form characterized by a generalized skeletal dysplasia involving mainly the spine and striking clinical abnormalities of the hands, in addition to classic features of Ehlers-Danlos syndrome. Clinical features include postnatal growth retardation, moderate short stature, protuberant eyes with bluish sclerae, hands with finely wrinkled palms, atrophy of the thenar muscles, and tapering fingers. Radiologic features include mild to moderate platyspondyly, mild to moderate osteopenia of the spine, small ileum, flat proximal femoral epiphyses, short, wide femoral necks, and broad metaphyses (elbows, knees, wrists, and interphalangeal joints).

EXPRESSÃO TECIDUAL(Ubíquo)
Aorta
93.2 TPM
Útero
92.3 TPM
Fibroblastos
87.5 TPM
Testículo
80.7 TPM
Nervo tibial
74.6 TPM
OUTRAS DOENÇAS (1)
Ehlers-Danlos syndrome, spondylocheirodysplastic type
HGNC:20859UniProt:Q96H72
B4GALT7Beta-1,4-galactosyltransferase 7Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Required for the biosynthesis of the tetrasaccharide linkage region of proteoglycans, especially for small proteoglycans in skin fibroblasts

LOCALIZAÇÃO

Golgi apparatus, Golgi stack membrane

VIAS BIOLÓGICAS (1)
Glycosaminoglycan-protein linkage region biosynthesis
MECANISMO DE DOENÇA

Ehlers-Danlos syndrome, spondylodysplastic type, 1

A form of Ehlers-Danlos syndrome, a group of connective tissue disorders characterized by skin hyperextensibility, articular hypermobility, and tissue fragility. EDSSPD1 is an autosomal recessive form characterized by short stature, developmental anomalies of the forearm bones and elbow, and bowing of extremities, in addition to the classic features of Ehlers-Danlos syndrome.

OUTRAS DOENÇAS (2)
Ehlers-Danlos syndrome, spondylodysplastic type, 1Ehlers-Danlos syndrome, spondylodysplastic type
HGNC:930UniProt:Q9UBV7
C1SComplement C1s subcomponentDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Component of the complement C1 complex, a multiprotein complex that initiates the classical pathway of the complement system, a cascade of proteins that leads to phagocytosis and breakdown of pathogens and signaling that strengthens the adaptive immune system (PubMed:11445589, PubMed:16169853, PubMed:417728, PubMed:467643, PubMed:6271784, PubMed:6282646, PubMed:6319179, PubMed:70787, PubMed:9422791). C1S is activated following association of the C1 complex with immunoglobulins (IgG or IgM) compl

LOCALIZAÇÃO

SecretedCell surface

VIAS BIOLÓGICAS (3)
Initial triggering of complementClassical antibody-mediated complement activationRegulation of Complement cascade
MECANISMO DE DOENÇA

Complement component C1s deficiency

A rare defect resulting in C1 deficiency and impaired activation of the complement classical pathway. C1 deficiency generally leads to severe immune complex disease with features of systemic lupus erythematosus and glomerulonephritis.

OUTRAS DOENÇAS (4)
Ehlers-Danlos syndrome, periodontal type 2complement component C1s deficiencyEhlers-Danlos syndrome, periodontitis typeimmunodeficiency due to a classical component pathway complement deficiency
HGNC:1247UniProt:P09871
COL1A2Collagen alpha-2(I) chainDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Type I collagen is a member of group I collagen (fibrillar forming collagen)

LOCALIZAÇÃO

Secreted, extracellular space, extracellular matrix

VIAS BIOLÓGICAS (10)
MET activates PTK2 signalingDevelopmental Lineage of Pancreatic Ductal CellsAssembly of collagen fibrils and other multimeric structuresECM proteoglycansFibronectin matrix formation
MECANISMO DE DOENÇA

Ehlers-Danlos syndrome, arthrochalasia type, 2

A form of Ehlers-Danlos syndrome, a connective tissue disorder characterized by hyperextensible skin, atrophic cutaneous scars due to tissue fragility and joint hyperlaxity. EDSARTH2 is an autosomal dominant condition characterized by frequent congenital hip dislocation and extreme joint laxity with recurrent joint subluxations and minimal skin involvement.

OUTRAS DOENÇAS (11)
combined osteogenesis imperfecta and Ehlers-Danlos syndrome 2Ehlers-Danlos syndrome, arthrochalasia type, 2osteogenesis imperfecta type 2osteogenesis imperfecta type 4
HGNC:2198UniProt:P08123
C1RComplement C1r subcomponentDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Serine protease component of the complement C1 complex, a multiprotein complex that initiates the classical pathway of the complement system, a cascade of proteins that leads to phagocytosis and breakdown of pathogens and signaling that strengthens the adaptive immune system (PubMed:17996945, PubMed:19473974, PubMed:29449492). C1R catalyzes the first enzymatic step in the classical complement pathway: it is activated by the C1Q subcomplex of the C1 complex, which associates with IgG or IgM immun

LOCALIZAÇÃO

SecretedCell surface

VIAS BIOLÓGICAS (3)
Initial triggering of complementClassical antibody-mediated complement activationRegulation of Complement cascade
MECANISMO DE DOENÇA

Ehlers-Danlos syndrome, periodontal type, 1

A form of Ehlers-Danlos syndrome, a connective tissue disorder characterized by hyperextensible skin, atrophic cutaneous scars due to tissue fragility and joint hyperlaxity. EDSPD1 is characterized by the association of typical features of Ehlers-Danlos syndrome with gingival recession and severe early-onset periodontal disease, leading to premature loss of permanent teeth. EDSPD1 inheritance is autosomal dominant.

OUTRAS DOENÇAS (4)
Ehlers-Danlos syndrome, periodontal type 1immunodeficiency due to a classical component pathway complement deficiencyEhlers-Danlos syndrome, periodontitis typeautosomal systemic lupus erythematosus type 16
HGNC:1246UniProt:P00736
FKBP14Peptidyl-prolyl cis-trans isomerase FKBP14Disease-causing germline mutation(s) inTolerante
FUNÇÃO

PPIase which accelerates the folding of proteins during protein synthesis. Has a preference for substrates containing 4-hydroxylproline modifications, including type III collagen. May also target type VI and type X collagens

LOCALIZAÇÃO

Endoplasmic reticulum lumen

VIAS BIOLÓGICAS (1)
XBP1(S) activates chaperone genes
MECANISMO DE DOENÇA

Ehlers-Danlos syndrome, kyphoscoliotic type, 2

A form of Ehlers-Danlos syndrome, a group of connective tissue disorders characterized by skin hyperextensibility, articular hypermobility, and tissue fragility. EDSKSCL2 is an autosomal recessive form characterized by severe generalized hypotonia at birth, myopathy, early-onset progressive kyphoscoliosis, joint hypermobility without contractures, hyperelastic skin with follicular hyperkeratosis, easy bruising, and occasional abnormal scarring, sensorineural hearing impairment, and normal pyridinoline excretion in urine.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
34.0 TPM
Pituitária
15.9 TPM
Cérebro - Hemisfério cerebelar
14.1 TPM
Aorta
13.2 TPM
Cervix Ectocervix
12.9 TPM
INTERAÇÕES PROTEICAS (1)
OUTRAS DOENÇAS (1)
Ehlers-Danlos syndrome, kyphoscoliotic type, 2
HGNC:18625UniProt:Q9NWM8
TNXBTenascin-XDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Appears to mediate interactions between cells and the extracellular matrix. Substrate-adhesion molecule that appears to inhibit cell migration. Accelerates collagen fibril formation. May play a role in supporting the growth of epithelial tumors

LOCALIZAÇÃO

Secreted, extracellular space, extracellular matrix

VIAS BIOLÓGICAS (1)
ECM proteoglycans
MECANISMO DE DOENÇA

Ehlers-Danlos syndrome, classic-like, 1

A form of Ehlers-Danlos syndrome, a group of connective tissue disorders characterized by skin hyperextensibility, articular hypermobility, and tissue fragility. EDSCLL1 patients lack atrophic scars, a major diagnostic criteria for classic Ehlers-Danlos syndrome. Delayed wound healing is only present in a subset of patients. EDSCLL1 inheritance is autosomal recessive.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Útero
68.1 TPM
Ovário
61.8 TPM
Cervix Endocervix
55.0 TPM
Nervo tibial
52.3 TPM
Tecido adiposo
51.1 TPM
OUTRAS DOENÇAS (3)
vesicoureteral reflux 8Ehlers-Danlos syndrome due to tenascin-X deficiencyfamilial vesicoureteral reflux
HGNC:11976UniProt:P22105
AEBP1Adipocyte enhancer-binding protein 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

As a positive regulator of collagen fibrillogenesis, it is probably involved in the organization and remodeling of the extracellular matrix May positively regulate MAP-kinase activity in adipocytes, leading to enhanced adipocyte proliferation and reduced adipocyte differentiation. May also positively regulate NF-kappa-B activity in macrophages by promoting the phosphorylation and subsequent degradation of I-kappa-B-alpha (NFKBIA), leading to enhanced macrophage inflammatory responsiveness. Can a

LOCALIZAÇÃO

SecretedCytoplasmNucleus

MECANISMO DE DOENÇA

Ehlers-Danlos syndrome, classic-like, 2

A variant form of Ehlers-Danlos syndrome, a connective tissue disorder. EDSCLL2 patients show severe joint and skin laxity, osteoporosis affecting the hips and spine, osteoarthritis, soft redundant skin that can be acrogeria-like, delayed wound healing with abnormal atrophic scarring, and shoulder, hip, knee, and ankle dislocations. Additional variable features include gastrointestinal and genitourinary manifestations (bowel rupture, gut dysmotility, cryptorchidism, and hernias), vascular complications (mitral valve prolapse and aortic root dilation), and skeletal anomalies. EDSCLL2 inheritance is autosomal recessive.

OUTRAS DOENÇAS (1)
Ehlers-Danlos syndrome, classic-like, 2
HGNC:303UniProt:Q8IUX7

Variantes genéticas (ClinVar)

3,000 variantes patogênicas registradas no ClinVar.

🧬 COL1A1: NM_000088.4(COL1A1):c.1060G>T (p.Glu354Ter) ()
🧬 COL1A1: NM_000088.4(COL1A1):c.616G>C (p.Gly206Arg) ()
🧬 COL1A1: NM_000088.4(COL1A1):c.724G>C (p.Gly242Arg) ()
🧬 COL1A1: NM_000088.4(COL1A1):c.2254G>A (p.Gly752Ser) ()
🧬 COL1A1: NM_000088.4(COL1A1):c.3433G>A (p.Gly1145Ser) ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 15,680 variantes classificadas pelo ClinVar.

784
7056
7840
Patogênica (5.0%)
VUS (45.0%)
Benigna (50.0%)
VARIANTES MAIS SIGNIFICATIVAS
PLOD1: GRCh37/hg19 1p36.22(chr1:12026307-12027148)x1 [Likely pathogenic]
COL5A2: NM_000393.5(COL5A2):c.1873G>T (p.Asp625Tyr) [Uncertain significance]
COL5A1: NM_000093.5(COL5A1):c.284C>A (p.Ala95Glu) [Uncertain significance]
COL5A1: NM_000093.5(COL5A1):c.3467_3469dup (p.Gly1156_Asp1157insGly) [Uncertain significance]
COL5A1: NM_000093.5(COL5A1):c.2393A>C (p.Asp798Ala) [Uncertain significance]

Vias biológicas (Reactome)

47 vias biológicas associadas aos genes desta condição.

GPVI-mediated activation cascade Collagen degradation Fibronectin matrix formation Collagen biosynthesis and modifying enzymes Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell Assembly of collagen fibrils and other multimeric structures Cell surface interactions at the vascular wall Integrin cell surface interactions Anchoring fibril formation Crosslinking of collagen fibrils Syndecan interactions Non-integrin membrane-ECM interactions ECM proteoglycans Scavenging by Class A Receptors GP1b-IX-V activation signalling Platelet Adhesion to exposed collagen Platelet Aggregation (Plug Formation) MET activates PTK2 signaling RUNX2 regulates osteoblast differentiation Collagen chain trimerization Enhanced cleavage of VWF variant by ADAMTS13 Enhanced binding of GP1BA variant to VWF multimer:collagen Defective VWF cleavage by ADAMTS13 variant Defective VWF binding to collagen type I Defective binding of VWF variant to GPIb:IX:V Developmental Lineage of Pancreatic Ductal Cells Platelet degranulation Cell-extracellular matrix interactions RHO GTPases activate PAKs OAS antiviral response Defective B3GALTL causes PpS O-glycosylation of TSR domain-containing proteins DS-GAG biosynthesis Signaling by PDGF NCAM1 interactions Attachment of bacteria to epithelial cells Glycosaminoglycan-protein linkage region biosynthesis Defective B3GALT6 causes EDSP2 and SEMDJL1 Defective CHST14 causes EDS, musculocontractural type Defective B4GALT7 causes EDS, progeroid type Initial triggering of complement Classical antibody-mediated complement activation Regulation of Complement cascade Dengue virus activates/modulates innate and adaptive immune responses SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription Interleukin-4 and Interleukin-13 signaling XBP1(S) activates chaperone genes

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
Aprovado1
3Fase 31
1Fase 11
·Pré-clínico17
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 20 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Síndrome Ehlers-Danlos

Centros de Referência SUS

24 centros habilitados pelo SUS para Síndrome Ehlers-Danlos

Centros para Síndrome Ehlers-Danlos

Detalhes dos centros

Hospital Universitário Prof. Edgard Santos (HUPES)

R. Dr. Augusto Viana, s/n - Canela, Salvador - BA, 40110-060 · CNES 0003808

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital Infantil Albert Sabin

R. Tertuliano Sales, 544 - Vila União, Fortaleza - CE, 60410-794 · CNES 2407876

Serviço de Referência

Rota
Anomalias CongênitasDeficiência Intelectual

Hospital de Apoio de Brasília (HAB)

AENW 3 Lote A Setor Noroeste - Plano Piloto, Brasília - DF, 70684-831 · CNES 0010456

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Estadual Infantil e Maternidade Alzir Bernardino Alves (HIABA)

Av. Min. Salgado Filho, 918 - Soteco, Vila Velha - ES, 29106-010 · CNES 6631207

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital das Clínicas da UFG

Rua 235 QD. 68 Lote Área, Nº 285, s/nº - Setor Leste Universitário, Goiânia - GO, 74605-050 · CNES 2338424

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital Universitário da UFJF

R. Catulo Breviglieri, Bairro - s/n - Santa Catarina, Juiz de Fora - MG, 36036-110 · CNES 2297442

Atenção Especializada

Rota
Anomalias Congênitas

Hospital das Clínicas da UFMG

Av. Prof. Alfredo Balena, 110 - Santa Efigênia, Belo Horizonte - MG, 30130-100 · CNES 2280167

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário Julio Müller (HUJM)

R. Luis Philippe Pereira Leite, s/n - Alvorada, Cuiabá - MT, 78048-902 · CNES 2726092

Atenção Especializada

Rota
Anomalias Congênitas

Hospital Universitário João de Barros Barreto

R. dos Mundurucus, 4487 - Guamá, Belém - PA, 66073-000 · CNES 2337878

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário Lauro Wanderley (HULW)

R. Tabeliao Estanislau Eloy, 585 - Castelo Branco, João Pessoa - PB, 58050-585 · CNES 0002470

Atenção Especializada

Rota
Anomalias Congênitas

Instituto de Medicina Integral Prof. Fernando Figueira (IMIP)

R. dos Coelhos, 300 - Boa Vista, Recife - PE, 50070-902 · CNES 0000647

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Pequeno Príncipe

R. Des. Motta, 1070 - Água Verde, Curitiba - PR, 80250-060 · CNES 3143805

Serviço de Referência

Rota
Anomalias CongênitasDeficiência Intelectual

Hospital Universitário Regional de Maringá (HUM)

Av. Mandacaru, 1590 - Parque das Laranjeiras, Maringá - PR, 87083-240 · CNES 2216108

Atenção Especializada

Rota
Anomalias Congênitas

Hospital de Clínicas da UFPR

R. Gen. Carneiro, 181 - Alto da Glória, Curitiba - PR, 80060-900 · CNES 2364980

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário Pedro Ernesto (HUPE-UERJ)

Blvd. 28 de Setembro, 77 - Vila Isabel, Rio de Janeiro - RJ, 20551-030 · CNES 2280221

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Instituto Nacional de Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira (IFF/Fiocruz)

Av. Rui Barbosa, 716 - Flamengo, Rio de Janeiro - RJ, 22250-020 · CNES 2269988

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital São Lucas da PUCRS

Av. Ipiranga, 6690 - Jardim Botânico, Porto Alegre - RS, 90610-000 · CNES 2232928

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital de Clínicas de Porto Alegre (HCPA)

Rua Ramiro Barcelos, 2350 Bloco A - Av. Protásio Alves, 211 - Bloco B e C - Santa Cecília, Porto Alegre - RS, 90035-903 · CNES 2237601

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário da UFSC (HU-UFSC)

R. Profa. Maria Flora Pausewang - Trindade, Florianópolis - SC, 88036-800 · CNES 2560356

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital das Clínicas da FMUSP

R. Dr. Ovídio Pires de Campos, 225 - Cerqueira César, São Paulo - SP, 05403-010 · CNES 2077485

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Base de São José do Rio Preto

Av. Brg. Faria Lima, 5544 - Vila Sao Jose, São José do Rio Preto - SP, 15090-000 · CNES 2079798

Atenção Especializada

Rota
Anomalias Congênitas

Hospital de Clínicas da UNICAMP

R. Vital Brasil, 251 - Cidade Universitária, Campinas - SP, 13083-888 · CNES 2748223

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas de Ribeirão Preto (HCRP-USP)

R. Ten. Catão Roxo, 3900 - Vila Monte Alegre, Ribeirão Preto - SP, 14015-010 · CNES 2082187

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

UNIFESP / Hospital São Paulo

R. Napoleão de Barros, 715 - Vila Clementino, São Paulo - SP, 04024-002 · CNES 2688689

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo
Sobre os centros SUS: Estes centros são habilitados pelo Ministério da Saúde como Serviços de Referência em Doenças Raras ou Serviços de Atenção Especializada. O atendimento é pelo SUS, com encaminhamento da rede de atenção básica.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

14 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

86 ensaios clínicos encontrados, 26 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

🥈Melhor nível de evidência: Observacional
Timeline de publicações
2.208 papers (10 anos)

Mostrando amostra de 200 publicações de um total de 2.208

#1

Children and adolescents with disorders of gut-brain interaction with comorbid hypermobility and orthostatic intolerance have worse outcomes.

Journal of pediatric gastroenterology and nutrition2026 Mar 19

Disorders of gut-brain interaction (DGBI) affect about 40% of children and are often comorbid with hypermobility spectrum disorders (HSDs) and orthostatic intolerance (OI). However, how these comorbidities impact outcomes in pediatric DGBI is not well understood. This study aimed to compare outcomes in DGBI patients with HSD, OI, both, or neither. We reviewed records of patients aged 9-21 years from a multidisciplinary DGBI clinic. Patients met Rome IV criteria for DGBI and had documented HSD and/or OI diagnoses from specialists in gastroenterology, rheumatology, genetics, cardiology, adolescent medicine, and others. HSD terms included Ehlers-Danlos syndrome, hypermobile Ehlers-Danlos syndrome, and generalized hypermobility; OI terms included postural orthostatic tachycardia syndrome, dysautonomia, and orthostatic hypotension. Clinical data included the following validated questionnaires: abdominal pain index, nausea severity scale, functional disability inventory, patient health questionnaire-9 (Depression), children somatization inventory, pediatric insomnia severity index, pain catastrophizing scale for children, and screen for child anxiety related disorders (Anxiety). We compared DGBI patients with both HSD and OI, those with either disorder, and those without. Of 175 patients, 46% had HSD and 43% had OI. Patients with both HSD and OI had significantly worse nausea, depression, disability, and somatization scores than others (p < 0.01). HSD and OI groups individually also showed worse outcomes than non-HSD/non-OI groups. Moderate correlations were found between depression and anxiety in OI and nausea and disability in HSD. Comorbid HSD and OI worsen DGBI symptoms. Accurate diagnosis and treatment are critical to improving outcomes due to shared autonomic dysfunction.

#2

Spontaneous coronary artery dissection and vascular Ehlers-Danlos syndrome: a systematic review and case series.

European journal of human genetics : EJHG2026 Mar 17

Spontaneous coronary artery dissection (SCAD) is a cause of acute myocardial infarction predominantly affecting adult women. A proportion of SCAD cases are associated with rare heritable connective tissue disorders. Vascular EDS (vEDS), due to deleterious variants in COL3A1, is one of the most common of these. Our aim was to identify specific features of SCAD in vEDS which may aid patient selection for genetic testing. A systematic review of published cases of individuals with SCAD and vEDS was conducted. Additionally, patients with SCAD and genetically confirmed vEDS (SCAD-vEDS) were identified through the UK national EDS service and UK SCAD registry. Data were collected on presentation, management and extra-cardiac findings. Angiography was compared with an age and sex-matched, exome sequenced, control cohort with SCAD but without vEDS (SCAD-nonvEDS). Data from ten SCAD-vEDS patients were identified. There was a lower average age of SCAD and higher proportion of males in individuals with SCAD-vEDS, however differences should be interpreted carefully given cohort size. Fifty-six cases of SCAD-vEDS were identified through systematic review. Systemic features were present in most but not all cases. This report presents a new, angiographically characterised case-control cohort along with a systematic review of the current literature. Whilst clinical differences appear between the SCAD-vEDS and SCAD-nonvEDS groups, these are insufficient to accurately distinguish SCAD-vEDS from the general SCAD population. All individuals with SCAD should be evaluated for underlying vEDS but clinical assessment will miss some cases. Wider genetic testing in some SCAD patients may be merited to enable appropriate management. Systematic review registration: https://www.crd.york.ac.uk/prospero/536751 Identifier: 536751.

#3

Generation of an induced pluripotent stem cell and isogenic control line from a vascular Ehlers-Danlos Syndrome (vEDS) patient harboring a pathogenic c.755G>T in the COL3A1 gene.

Stem cell research2026 Apr

We report the generation and characterization of a collagen III-mutant human iPSC line (JHUi007-A) and an isogenic gene-edited control (JHUi007-A-1). Reprogramming of dermal fibroblasts, obtained from a patient with vascular Ehlers-Danlos syndrome (vEDS) carrying the COL3A1 c.755G>T variant, was performed using integration-free Sendai virus. Isogenic controls were produced by CRISPR/Cas9 gene editing. Both lines displayed typical morphologies, expressed stemness factors, formed derivatives of all three germ layers, and maintained a normal karyotype. These lines readily differentiated into vascular smooth muscle cells with cytoskeletal differences between vEDS and control cells, confirming the utility of this resource to study disease processes.

#4

Prevalence of Intracranial and Cervical Artery Abnormalities in Patients with Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders Presenting to an Academic Headache Clinic.

Neurology international2026 Feb 11

Background/Objective: It remains unknown whether patients with the more common forms of hypermobility carry an elevated risk for the development of intracranial/cervical artery abnormalities. The objective of this study was to determine the prevalence of unruptured intracranial aneurysms, spontaneous cervical artery dissections, and fibromuscular dysplasia in patients with hypermobile Ehlers-Danlos Syndrome (hEDS) and hypermobility spectrum disorders (HSD) who presented to an academic headache clinic. Methods: This is a retrospective cohort study. We used an electronic medical record to look for all patients seen at the Mayo Clinic Florida Headache Center and EDS Clinic between 2019 and 2025 with a diagnosis of hEDS or HSD and neuroimaging of both the intracranial and cervical arteries. Results: There were 103 patients who met the inclusion criteria. There was no statistically significant difference between hEDS and HSD patients in developing cerebral/cervical arterial anomalies. Of the sample, 95% of the hypermobile patients with abnormal neuroimaging also had migraine. A total of eleven (10.7%) patients (hEDS + HSD) were diagnosed with unruptured intracranial aneurysms. Trends included age less than 50 years, small aneurysms in the anterior circulation, and having migraine with aura. Five (4.8%) patients were diagnosed with spontaneous cervical artery dissection with trends for HSD, over the age of 50 years, vertebral artery involvement and a history of migraine without aura. Six (5.8%) patients were diagnosed with fibromuscular dysplasia with trends for HSD, over the age of 50 years, carotid artery involvement and a history of migraine with aura. Conclusions: This is the first study to identify that patients with the more common type of EDS, HSD and hEDS, and a possible concomitant history of migraine have a heightened risk for the development of unruptured intracranial aneurysms, spontaneous cervical artery dissections, and fibromuscular dysplasia. Our findings suggest the need for targeted screening with intracranial and extracranial arterial imaging for this unique patient population.

#5

Shared autonomic phenotype of long COVID and myalgic encephalomyelitis/chronic fatigue syndrome.

PloS one2026

Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) are relatively common and disabling multisystem disorders that share overlapping features, including post-infectious onset and similar clinical manifestations such as brain fog, fatigue, muscle pain, and dysautonomia with orthostatic intolerance. These similarities suggest that Long COVID and ME/CFS may share common pathophysiological mechanisms, though the underlying mechanisms remain poorly understood, partly due to the difficulty in quantifying many of the symptoms. This retrospective study evaluated Long COVID and pre-COVID ME/CFS patients who completed autonomic testing between 2018 and 2023 at the Brigham and Women's Faulkner Hospital Autonomic Laboratory. The evaluations included autonomic tests (Valsalva maneuver, deep breathing, tilt-table test, and sudomotor function) with capnography and transcranial Doppler monitoring of cerebral blood flow velocity (CBFv) in the middle cerebral artery, neuropathic assessment through skin biopsies for small fiber neuropathy (SFN), invasive cardiopulmonary exercise testing (ICPET), and laboratory analyses covering metabolic, inflammatory, autoimmune, and hormonal profiles. A total of 143 Long COVID and 170 ME/CFS patients were analyzed and compared to 73 healthy controls and 290 patients with hypermobile Ehlers-Danlos syndrome (hEDS). Tests revealed extensive similarities between Long COVID and ME/CFS, including reduced orthostatic CBFv (92%/88% in Long COVID/ME/CFS), mild-to-moderate widespread autonomic failure (95%/89%), presence of SFN (67%/53%), postural tachycardia syndrome (POTS) (22%/19%), neurogenic orthostatic hypotension (15%/15%) and preload failure (96%/92%, assessed in 25/66 Long COVID/ME/CFS). Patients with hEDS exhibited more severe peripheral neurodegeneration compared to the other groups. Laboratory tests did not distinguish between the conditions. Both Long COVID and ME/CFS demonstrate dysregulation in cerebrovascular blood flow, autonomic reflexes, and small fiber neuropathy, suggesting that these conditions may share a common underlying pathophysiology. However, differing distributions of findings in patients with hEDS raise the question of whether these conditions represent distinct but overlapping syndromes or reflect a shared underlying pathway. Further research is required to clarify the relationship between these conditions and the potential underlying pathophysiological mechanisms.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC3.240 artigos no totalmostrando 200

2026

Sleep-Related Hypoventilation in a Patient With Ehlers-Danlos Syndrome.

Cureus
2026

Pulmonary hemorrhage as an early clue: an integrated clinical-imaging-genetic diagnostic insight for vascular Ehlers-Danlos syndrome.

Orphanet journal of rare diseases
2026

Craniocervical instability after inadvertent neck hyperextension in Ehlers-Danlos syndrome: a retrospective case series and literature review.

BMC neurology
2026

Aortic dissection during the perinatal period in women with Marfan-related disorders: a retrospective cohort study using the Japanese Diagnosis Procedure Combination database.

The journal of maternal-fetal &amp; neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
2026

A laboratory micro-CT technique is useful to visualize and characterize dermal skin components in a 3D manner.

Experimental and therapeutic medicine
2026

Children and adolescents with disorders of gut-brain interaction with comorbid hypermobility and orthostatic intolerance have worse outcomes.

Journal of pediatric gastroenterology and nutrition
2026

Implications of Dermatologic Disorders in Facial Cosmetic Surgery: A Systematic Review.

Annals of plastic surgery
2026

Spontaneous coronary artery dissection and vascular Ehlers-Danlos syndrome: a systematic review and case series.

European journal of human genetics : EJHG
2026

Treating Ehlers-Danlos Syndrome in moderate crowding Class I cases.

Journal of clinical orthodontics : JCO
2026

Oral Manifestations of Non Vascular Ehlers-Danlos Syndrome Cross-Sectional Study.

Oral diseases
2026

Surgical screening protocol for craniocervical instability secondary to ehlers-danlos syndrome and other connective tissue disorders: analysis of a 347 patient case series.

Neurosurgical review
2025

[Analysis of clinical features and genetic variants in a Chinese pedigree affected with Spondyloepiphyseal dysplasia type Ehlers-Danlos syndrome due to variants of B3GALT6 gene].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2026

Vascular Ehlers-Danlos syndrome with ruptured thoracic aortic aneurysm complicated by vascular graft and endograft infection and aortobronchial fistula.

Journal of vascular surgery cases and innovative techniques
2026

Impaired attention and cognitive deficits associated with pain and autonomic symptoms in hypermobile Ehlers-Danlos syndrome: a pilot study.

Clinical autonomic research : official journal of the Clinical Autonomic Research Society
2026

Efficacy of Lidocaine Infusion in the Management of Chronic Myofascial Pain and Intractable Migrainous Headache in a Patient With Hypermobile Ehlers-Danlos Syndrome: A Case Report.

Cureus
2026

Proximity extension assay-based serum proteomic profiling identifies shared protein signatures in hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders.

Clinical proteomics
2026

Timely Diagnosis and Management in Adult Patients With Ehlers-Danlos Syndrome Experiencing Gynaecological Bleeding.

Haemophilia : the official journal of the World Federation of Hemophilia
2026

Patients with Ehlers-Danlos syndrome experience reduced effectiveness of lidocaine local anesthetic: a randomized cross-over clinical trial.

Regional anesthesia and pain medicine
2026

In-Vivo Force-Length Relationship of the Medial Gastrocnemius Muscle in Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders.

Journal of musculoskeletal &amp; neuronal interactions
2026

Multi-System Genetic Architecture of Hypermobile Ehlers-Danlos Syndrome: Integrating Machine Learning with Subject-Level Genomic Analysis.

Genes
2026

Generation of an induced pluripotent stem cell and isogenic control line from a vascular Ehlers-Danlos Syndrome (vEDS) patient harboring a pathogenic c.755G>T in the COL3A1 gene.

Stem cell research
2026

Prevalence of Intracranial and Cervical Artery Abnormalities in Patients with Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders Presenting to an Academic Headache Clinic.

Neurology international
2025

Arteriopathies: Too big to be true.

Annals of pediatric cardiology
2026

An Online Pilates Program for People with Hypermobility: A Pragmatic Clinical Trial Looking at Function, Interoception, Kinesiophobia, and Physical Activity Levels.

Journal of multidisciplinary healthcare
2026

Health experiences and outcomes of autistic and non-autistic adults with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorder.

BMC medicine
2026

TikTok as a Platform for Patient Education and Health Information in Rare Genetic Diseases: Cross-Sectional Study.

JMIR formative research
2026

Developmental, but not Homeostatic, Collagen V Expression Regulates Mature Murine Supraspinatus Tendon Structure, Function, and Gene Expression.

Journal of orthopaedic research : official publication of the Orthopaedic Research Society
2026

Bend the fingers: Ehlers Danlos syndrome and the associated disorders that impact treatment of chronic musculoskeletal pain.

Journal of back and musculoskeletal rehabilitation
2026

Genetic testing in thoracic aortic disease: diagnostic performance of the 2024 ESC algorithm.

European heart journal
2026

Beyond antifungals: vaginal ceramides as a barrier-restorative strategy for recurrent vulvovaginal candidiasis in Ehlers-Danlos syndrome.

Annals of medicine and surgery (2012)
2026

A comparison of reverse shoulder arthroplasty and glenohumeral arthrodesis for end-stage shoulder instability.

JSES international
2026

Robotic-assisted Left Pneumonectomy For Vanishing Lung Syndrome.

Journal of visualized experiments : JoVE
2026

Sex differences in self-reported symptoms and comorbidities associated with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders: A retrospective study.

Research square
2026

Contemporary Outcomes of Thoracic Endovascular Aortic Repair in Patients with Syndromic Genetic Aortopathy: A Multi-Centre National Study.

Annals of vascular surgery
2026

The transitional pain service: a narrative review on the approach to managing chronic post-surgical pain.

Journal of anesthesia
2026

Development and evaluation of a vision pose-tracking based Beighton score tool for generalized joint hypermobility in individuals with suspected Ehlers-Danlos syndromes.

Biomedical engineering online
2026

Safety and Impacts of Physical Activity for Individuals Living With Hypermobility Spectrum Disorders and Hypermobile Ehlers-Danlos Syndrome: Protocol for a Scoping Review.

JMIR research protocols
2026

Idiopathic Localized Acquired Cutis Laxa in an Adult Male: A Case Report.

Cureus
2026

The role of perceived social support for outcomes for the long-term health condition hypermobile Ehlers-Danlos syndrome.

Journal of health psychology
2026

Tenascin-XB plays a role in the infiltration of immune cells in tumor microenvironment.

Biomedical research (Tokyo, Japan)
2026

Intercostal nerve radiofrequency ablation for slipping rib syndrome: a case report.

Pain management
2026

Sex differences in aortopathy, arteriopathy, and mortality in vascular Ehlers-Danlos syndrome.

Journal of vascular surgery
2025

Kyphoscoliotic Ehlers-Danlos syndrome associated with superior mesenteric artery aneurysm and abdominal aortic rupture: a case report.

Frontiers in pediatrics
2026

Complications and Management of Ehlers-Danlos Syndromes and Hypermobility Spectrum Disorders: A Literature Review.

Orthopedic nursing
2025

Case Report: Neuropsychiatric improvement after treatment of pelvic venous disorder in a multisyndromic patient.

Frontiers in cardiovascular medicine
2025

Reasons for Participating in the EDS-HEART Program: Holistic and Performative Within a Supportive Community.

International journal of environmental research and public health
2026

Health-Related Quality of Life in Midlife and Older Women With Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders.

Nursing for women's health
2026

Spontaneous celiac artery dissection revealing vascular Ehlers-Danlos syndrome.

The American journal of medicine
2026

Shared autonomic phenotype of long COVID and myalgic encephalomyelitis/chronic fatigue syndrome.

PloS one
2026

[Open Thoracoabdominal Aortic Replacement for Midaortic Syndrome and COL3A1 Variant].

Zentralblatt fur Chirurgie
2026

Association between Ehlers-Danlos syndrome and mast cell activation syndrome: Is there scientific evidence?

Revista clinica espanola
2026

A typical canine Ehlers-Danlos-like syndrome without collagen abnormalities: a suspected case of Tenascin-X deficiency.

BMC veterinary research
2025

Surgical Management of Combined Patellofemoral and Proximal Tibiofibular Joint Instability in a Patient With Ehlers-Danlos Syndrome.

Arthroscopy techniques
2026

Postoperative complications following tonsillectomy in children with Ehlers-Danlos Syndrome.

International journal of pediatric otorhinolaryngology
2025

Heart Rate Variability and Intrinsic Autonomic Coupling in Ehlers-Danlos Syndrome.

Cureus
2026

Scroll, like, diagnose? Evaluating mast cell activation syndrome information on TikTok.

Allergy and asthma proceedings
2026

Joint hypermobility syndrome for the urogynaecologist - A narrative review.

European journal of obstetrics, gynecology, and reproductive biology
2026

Genetic Determinants of Wound Healing: Monogenic Disorders and Polygenic Influence.

Cells
2026

Vascular Phenotype of Kyphoscoliotic Ehlers-Danlos Syndrome.

Indian journal of pediatrics
2026

Outcomes and experiences of patients with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders undergoing surgical interventions: a scoping review.

Rheumatology international
2026

Pulmonary Vascular Abnormalities and Spontaneous Pneumothorax in Loeys-Dietz Syndrome.

Pathology international
2025

Novel Use of Meniscal Allograft Arthroplasty for Basal Joint Arthritis in a Patient With Ehlers-Danlos Syndrome: A Case Report.

Cureus
2026

Chiari type 1 malformations and hypermobility spectrum disorder: clinical outcomes and the importance of the differential diagnosis.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2026

Violaceous Pretibial Plaques: A Clue to Periodontal Variant of Ehlers-Danlos Syndrome.

Fetal and pediatric pathology
2026

Nutrient intake, dietary patterns and relationship to symptoms and comorbidities in hypermobile Ehlers-Danlos syndrome.

Clinical nutrition (Edinburgh, Scotland)
2025

Bilateral Cranial Cruciate Ligament Rupture Treatment in a Dog Affected by Classical Ehlers-Danlos Syndrome.

Veterinary sciences
2025

A de novo variant of the COL3A1 gene: causality of vascular Ehlers-Danlos syndrome.

Advances in laboratory medicine
2025

A Family with Meester-Loeys Syndrome Caused by a Novel Missense Variant in the BGN Gene.

International journal of molecular sciences
2025

Assessment of Collagen and Fibroblast Properties via Label-Free Higher Harmonic Generation Microscopy in Three-Dimensional Models of Osteogenesis Imperfecta and Ehlers-Danlos Syndrome.

International journal of molecular sciences
2025

Clinical Presentation, Diagnostic Delays, and Treatment Outcomes in Postural Orthostatic Tachycardia Syndrome (POTS): An Observational Case Series Study in a Single-Centre District General Hospital.

Cureus
2025

Comprehensive Risk Profile of Gastrointestinal and Extra Articular Comorbidities in Ehlers-Danlos Syndrome: A Propensity-Matched Analysis of 118,256 Individuals.

Alimentary pharmacology &amp; therapeutics
2025

The association of point-of-care coagulation testing with bleeding symptoms in patients with Ehlers-Danlos syndrome: an exploratory cross-sectional study.

Canadian journal of anaesthesia = Journal canadien d'anesthesie
2025

Chest Imaging Findings and Tissue Biopsy Experience in a Patient with Type IV Ehlers-Danlos Syndrome: A Case Report.

Journal of the Korean Society of Radiology
2025

Comprehensive genetic screening of in vitro fertilized embryos using preimplantation genetic testing for monogenic gene disorders via the Sanger sequencing technique.

Molecular biology reports
2025

A Caregiver's Perspective: Identifying "Zebras"-Listening to Patients is a Clinical Necessity.

Journal of patient experience
2025

Perceived quality of life, fatigue and the metabolic cost of walking in generalized hypermobility spectrum disorder and hypermobile Ehlers-Danlos syndrome.

Frontiers in rehabilitation sciences
2025

Sources and consequences of self-doubt in patients with Ehlers-Danlos syndrome: a qualitative study in Europe and North America.

BMJ open
2025

Challenges in the Management of Patients with Vascular Ehlers-Danlos Syndrome: Lessons from three Clinical Cases.

European journal of case reports in internal medicine
2025

Underlying Aortopathies in Pregnancy: Early Detection, Management, and Advanced Planning.

Cardiology in review
2025

Surgical management of progressive spinal deformities in FKBP14-associated Ehlers-Danlos syndrome: a case report and literature review.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2026

Distressing Bleeding Symptoms in Interviews of Patients With Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorder.

Haemophilia : the official journal of the World Federation of Hemophilia
2025

Diaphragmatic Hernia in a Newborn With COL1A1-Associated Classical Ehlers-Danlos Syndrome.

Case reports in genetics
2026

Environmental exposures, epithelial barrier dysfunction, and the evolving landscape of allergic disorders and asthma.

Current opinion in allergy and clinical immunology
2026

Aortic Tissue Proteome Alterations in Vascular Ehlers-Danlos Syndrome.

Journal of proteome research
2026

Clinical utility of chromosomal microarray and whole exome sequencing in evaluating genetic causes for pregnancy loss using products of conception specimens.

Journal of perinatal medicine
2026

Human Proteoglycan Linkage Region Glycosyltransferases are Dimeric and Show Unexpected Specificities.

Angewandte Chemie (International ed. in English)
2025

Hybrid prosthesis in frozen elephant trunk procedures for hereditary thoracic aortic diseases: a 14-year single-aortic center experience.

Journal of cardiothoracic surgery
2025

What Factors and Patient-reported Outcome Measures Are Associated With Stress Fracture After Periacetabular Osteotomy?

Clinical orthopaedics and related research
2025

Compression garments in hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders: a retrospective cohort study.

BMC musculoskeletal disorders
2025

To Ground Research in the Lived Experience of Patients and Caregivers, Give Us a Voice!

Annals of family medicine
2026

Platelet defects in patients and mice with Ehlers-Danlos syndrome.

Blood
2025

Understanding Comorbidities in Hypermobile Ehlers-Danlos Syndrome: Could a Viral Infection Lead to a Diagnosis?

medRxiv : the preprint server for health sciences
2025

Functional analysis of a novel variant in the COL5A1 gene in a Polish patient with the classical type of Ehlers-Danlos syndrome.

Frontiers in genetics
2025

Pulmonary vascular Ehlers-Danlos syndrome with hemoptysis as the main manifestation: CT and histologic findings of lung parenchymal damage.

Orphanet journal of rare diseases
2026

To what extent do the muscles and tendons influence metabolic cost and exercise tolerance in the hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders?

Clinical biomechanics (Bristol, Avon)
2025

Comparative assessment of left common iliac vein compression in patients with hypermobile Ehlers-Danlos syndrome, hypermobility spectrum disorder and healthy controls - A retrospective single-centre study.

Phlebology
2025

Hypothesis paper: high prevalence of Tinel sign in hypermobile Ehlers-Danlos syndrome.

Frontiers in neurology
2025

Neurobiological and neuropsychological disturbance in EDS.

Frontiers in neurology
2025

Treatment Modalities, Pain Response, and Referrals for Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders: A Retrospective Study.

Mayo Clinic proceedings. Innovations, quality &amp; outcomes
2026

Multimodality Imaging for Thoracic Aortic Aneurysms.

Cardiology clinics
2026

Aebp1 loss in osteoprogenitors leads to skeletal defects resembling Ehlers-Danlos Syndrome by diminishing Wnt/β-catenin signaling.

JCI insight
2025

Associations Between Pain and Substance Use Among Individuals Diagnosed with Ehlers-Danlos Syndromes or Generalized Hypermobility Spectrum Disorder.

International journal of behavioral medicine
2025

Aggressive clinical course of vascular Ehlers-Danlos syndrome with a novel COL3A1 variant.

BMJ case reports
2025

Nonoperative Management of Infectious Mononucleosis-Associated Splenic Rupture: A Case Report.

WMJ : official publication of the State Medical Society of Wisconsin
2025

Connective tissue changes in Ehlers-Danlos syndromes with and without axial spondyloarthropathy.

Journal of ultrasound
2025

Rare vascular presentation of PLOD1-related kyphoscoliotic Ehlers-Danlos syndrome in 10-year-old girl with severe arterial complications.

Kardiologia polska
2026

Elucidating the Molecular Basis in a Cohort of Patients With Combined Bleeding Tendencies and Joint Hypermobility Manifestations.

Haemophilia : the official journal of the World Federation of Hemophilia
2025

No association between joint hypermobility, musculoskeletal pain and neurodevelopmental problems in a school-based sample of 11-year-old children.

BJPsych open
2025

Postpartum Presentation of a Variant of Uncertain Significance in COL3A1: A Case Report.

American journal of perinatology
2025

Co-morbid monogenic disorders at chromosome region 1q2: LMNA- and FLG-related disorders in a patient referred for assessment of joint hypermobility.

Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology
2025

Joint Hypermobility: An Under-Recognised Cause of Palpitations, Dizziness, and Syncope in Young Females.

Journal of clinical medicine
2025

Hypermobile Ehlers-Danlos Syndrome With Prominent Gastrointestinal and Autonomic Involvement in a Latin American Patient: A Case Report.

Cureus
2025

Ehlers-Danlos Syndrome: A Tale of Two Cases Highlighting Rare Subtypes and Diagnostic Considerations.

Cureus
2025

Wearable technology in the management of complex chronic illness: preliminary survey results on self-reported outcomes.

Frontiers in digital health
2025

How do people with disability and complex needs experience the built environment in apartments designed for people with disability?

Australian occupational therapy journal
2025

Autonomic symptom burden, comorbidities and quality of life in women with Hypermobility Spectrum Disorders and hypermobile Ehlers-Danlos syndrome.

Autonomic neuroscience : basic &amp; clinical
2026

Exploring Transdiagnostic Eating Disorder Symptoms and Disorder of Gut-Brain Interaction Symptoms in Individuals With Connective Tissue Disorders.

The International journal of eating disorders
2025

Intersecting Pathologies: COL1A1-Related Syndrome in the Setting of Childhood-Onset Hypopituitarism: Case Report and Literature Review.

Diagnostics (Basel, Switzerland)
2025

Percutaneous transhepatic coil embolisation of a common hepatic artery aneurysm in vascular Ehlers-Danlos syndrome.

CVIR endovascular
2025

Idiopathic intracranial hypertension and Ehlers-Danlos syndrome: a case series.

Journal of neurology
2025

Outcomes of revisional bariatric surgery in patient with hypermobile Ehlers-Danlos syndrome.

Journal of surgical case reports
2025

Intramuscular hemorrhage during rehabilitation in a post-stroke patient with vascular Ehlers-Danlos syndrome: a case report and review of spasticity-related muscle injury.

Frontiers in rehabilitation sciences
2025

Exploring the Association Between Median Arcuate Ligament Syndrome and Hypermobile Ehlers-Danlos Syndrome: A Case Report.

Cureus
2025

Clinical application of radiofrequency echographic multi-spectrometry (REMS) for diagnosis and follow-up in several rare bone disorders: a case series.

BMC medical imaging
2025

Novel ATP7A Splice-Site Variant Causing Distal Motor Neuropathy and Occipital Horn Syndrome: Two Siblings and Literature Review.

Genes
2025

Anti-Nuclear Antibody (ANA) Positivity and Nuclear Antigen Reactivity in Patients with Joint Hypermobility Syndrome/Hypermobile Ehlers Danlos Syndrome (JHS/hEDS).

Biomedicines
2025

Health Care Content and Engagement in Chronic Illness Instagram Posts: Content Analysis.

JMIR formative research
2025

Complex Genetics and Regulatory Drivers of Hypermobile Ehlers-Danlos Syndrome: Insights from Genome-Wide Association Study Meta-analysis.

medRxiv : the preprint server for health sciences
2025

Evidence of Altered Enteric Nervous System Structure Associated With Severe Dysmotility in a Patient With Ehlers-Danlos Syndrome.

ACG case reports journal
2025

Caution Remains Warranted in Pregnancy With Vascular Ehlers-Danlos Syndrome.

BJOG : an international journal of obstetrics and gynaecology
2025

Complex Wound Reconstruction in a Patient With Ehlers-Danlos Syndrome.

Plastic and reconstructive surgery. Global open
2026

Prevalence of Hypermobile Ehlers-Danlos Syndrome in Transgender and Gender Diverse Individuals: A Retrospective Cohort Study.

LGBT health
2025

A Rare Tetrad of Sickle Cell Disease, Vascular Ehlers-Danlos Syndrome, Primary Ciliary Dyskinesia, and Phelan-McDermid Syndrome in a Saudi Child: A Complex Multisystem Pediatric Case Report.

Pediatric reports
2025

Improvement in Upper Limb and Systemic Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Symptoms After Surgical Treatment of Neurogenic Thoracic Outlet Syndrome.

Cureus
2026

Pathologies of the cervical spine in skeletal syndromes and dysplasias.

Orthopaedics &amp; traumatology, surgery &amp; research : OTSR
2025

Proteomic discoveries in hypermobile Ehlers-Danlos syndrome reveal insights into disease pathophysiology.

ImmunoHorizons
2025

Interventional varicose vein therapy using endoluminal laser ablation (1940 nm) in patients with Ehlers-Danlos syndromes: two case reports.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
2025

Periodontal Manifestations of Systemic Diseases.

Journal of periodontal research
2025

Heightened Revision Risk After Ankle Ligament Repair in Patients With Ehlers-Danlos Syndrome or Hypermobility Spectrum Disorder: A Propensity-Matched National Database Study.

Foot &amp; ankle international
2025

KLK15 alters connective tissues in hypermobile Ehlers-Danlos syndrome.

iScience
2025

Varied Presentations of Arterial Events in Vascular Ehlers-Danlos Syndrome.

JACC. Case reports
2025

[Vascular Ehlers-Danlos syndrome discovered after splenic aneurysm rupture: a case report].

Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology
2025

Conservative Management of Massive Retroperitoneal Hemorrhage in a Patient with Vascular Ehlers-Danlos Syndrome: A Case Report.

Vascular specialist international
2025

Mitral annular disjunction distance is associated with adverse outcomes in children and young adults with connective tissue disorders.

Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance
2025

Anesthetic Management of a Pregnant Patient With Ehlers-Danlos Syndrome Undergoing Elective Cesarean Delivery: A Case Report.

Cureus
2025

Median arcuate ligament syndrome: challenges, comorbidities, and controversies.

Current opinion in pediatrics
2025

Postdural Puncture Headache in a Patient With Thoracic Arachnoid Web With Known Joint Hypermobility: Case Report.

Pain medicine case reports
2026

[Ehlers-Danlos syndromes: Diagnosis and care pathway of these complex and multisystemic diseases].

La Revue de medecine interne
2025

A Novel PTCH1 Non-Canonical Splice Region Variant Associated with Gorlin Syndrome: A Case Report.

Molecular syndromology
2025

Unveiling the Spectrum: Clinical and Molecular Insights from a Spanish Pediatric Cohort with Hypermobility Disorders and Ehlers-Danlos Syndrome.

Genes
2025

Defining the Chronic Complexities of hEDS and HSD: A Global Survey of Diagnostic Challenges, Life-Long Comorbidities, and Unmet Needs.

Journal of clinical medicine
2025

Localized and historical hypermobile spectrum disorders share self-reported symptoms and comorbidities with hEDS and HSD.

Frontiers in medicine
2026

A unique case of prenatal diagnosis of vascular Ehlers-Danlos syndrome.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
2025

Case Report: A rare presentation of vascular Ehlers-Danlos syndrome with a massive hemothorax and a chest wall hematoma.

Frontiers in medicine
2025

Exploring patient experiences of pain fatigue and physical activity in syndromic heritable thoracic aortic disease using mixed methods.

Scientific reports
2025

B3GALT6 mutations lead to compromised connective tissue biomechanics in Ehlers-Danlos syndrome.

JCI insight
2026

Collagen V Influences Homeostatic Maintenance of Patellar Tendon Failure Properties in Mature Female Mice.

Journal of orthopaedic research : official publication of the Orthopaedic Research Society
2025

Hypermobile Ehlers-Danlos Syndrome: Cerebrovascular, Autonomic and Neuropathic Features.

American journal of medicine open
2025

ADAMTS2: More than a procollagen N-proteinase.

Genes &amp; diseases
2025

Association Between Ehlers-Danlos Syndrome and Celiac Disease.

Gastro hep advances
2025

Navigating the psychosocial landscape of Ehlers-Danlos syndrome: an autobiographic case study.

Discover mental health
2025

Health care supply in patients with Ehlers-Danlos syndromes and generalized hypermobility spectrum disorder: a German perspective.

Orphanet journal of rare diseases
2025

Fragility in Focus: Gallbladder Rupture in a Patient With Vascular Ehlers-Danlos Syndrome.

ANZ journal of surgery
2025

Outcomes of fenestrated-branched endovascular aortic repair of thoracoabdominal aortic aneurysms in patients with heritable thoracic aortic diseases.

JTCVS techniques
2025

Vascular findings in five unrelated children with vascular Ehlers-Danlos syndrome: A multi-case report.

European journal of medical genetics
2025

A Case of Complex Regional Pain Syndrome With Hypermobile Ehlers-Danlos Syndrome and Mast Cell Activation Syndrome: The Role of Unconventional Therapies.

Cureus
2025

Risk factors of patellofemoral instability in patients with hypermobile Ehlers-Danlos syndrome.

Archives of orthopaedic and trauma surgery
2025

Survival of anterior cruciate ligament  reconstruction in patients with Ehlers-Danlos syndrome: A comparison with anatomic risk factors in existing literature.

International orthopaedics
2025

"There's no one-size-fits-all kind of solution": An interpretative phenomenological analysis of the experiences of autistic individuals living with Ehlers-Danlos syndrome.

Research in developmental disabilities
2025

Ketamine Use in a Laboring Mother With Type 4 Ehlers-Danlos Syndrome, a Family History of Malignant Hyperthermia, and Opioid-Induced Seizures.

Cureus
2025

[Diagnostic value of whole exome sequencing in difficult and complicated pulmonary diseases].

Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases
2025

Post-tonsillectomy risks in patients with Ehlers-Danlos syndrome.

International journal of pediatric otorhinolaryngology
2026

Refractory Gastrojejunal Anastomosis Stenosis After TORe in a Patient with Ehlers-Danlos Syndrome.

Digestive diseases and sciences
2026

Hypovolemic shock due to massive subcutaneous hemorrhage in a patient with musculocontractural Ehlers-Danlos syndrome (mcEDS).

Wiener klinische Wochenschrift
2025

Non-Traumatic Arytenoid Subluxation in a Patient With Hypermobile Ehlers-Danlos Syndrome.

The Laryngoscope
2024

Diagnosis of vascular Ehlers Danlos syndrome and management of vascular complications: a vascular surgeons perspective.

Medizinische Genetik : Mitteilungsblatt des Berufsverbandes Medizinische Genetik e.V
2025

'Pediatric Ehlers-Danlos syndrome VI with retroperitoneal Hemorrhage: case report and management strategy'.

Oxford medical case reports
2025

Ehlers-Danlos syndrome and the risk of spontaneous colonic perforation: clinical insights and surgical implications.

Journal of surgical case reports
2025

Voice Disorders in Ehlers-Danlos Syndrome.

American journal of speech-language pathology
2025

Diverticulitis: A Review.

JAMA
2025

Sleep Characteristics in Individuals with Ehlers-Danlos Syndrome.

Medical sciences (Basel, Switzerland)
2025

Double-Allograft Shoulder Stabilization for Multidirectional Instability Is Associated With Improved Function and Survivability After 2 Years.

Arthroscopy, sports medicine, and rehabilitation
2025

Soft Tissue Stabilization of Midcarpal Instability in Ehlers-Danlos Patients Using a Cadaveric Tendon Graft.

Plastic and reconstructive surgery. Global open
2025

Association Between Orthostatic Intolerance Symptoms and Cognitive Complaints in Hypermobile Ehlers-Danlos Syndrome (hEDS) and Joint Hypermobility Spectrum Disorder (JHSD): A Cross-Sectional Analysis.

Cureus
2025

Abdominal Compression Syndromes in the Hypermobile Ehlers-Danlos Syndrome.

American journal of medical genetics. Part A
2025

Severely Kinked Ascending Aorta Prosthetic Graft Causing Thromboembolism.

JACC. Case reports
2025

Orthopaedic Manifestations in Hypermobile Ehlers-Danlos Syndrome.

The Journal of bone and joint surgery. American volume
2025

Exploring physical activity patterns in adolescents with hypermobility spectrum disorder or hypermobile Ehlers-Danlos Syndrome.

Pediatric rheumatology online journal
2025

Features of Vulvodynia Associated With Ehlers-Danlos Syndrome.

Journal of lower genital tract disease
2025

User-Driven Development of a Digital Behavioral Intervention for Chronic Pain: Multimethod Multiphase Study.

JMIR formative research
2025

Genetic Diseases Mimicking Rheumatic Disorders: Insights From Southeastern Turkey.

American journal of medical genetics. Part A
2025

The importance of stabilisation in enabling bone fusion demonstrated by successful revision of failed occipitocervical fusion using patient-specific atlantoaxial joint spacers: a case report.

Journal of spine surgery (Hong Kong)
2025

Walking and running in people who are hypermobile: A scoping review.

Gait &amp; posture
2025

Oral and maxillofacial clinical features of Ehlers-Danlos syndrome: a systematic review.

Oral surgery, oral medicine, oral pathology and oral radiology
2025

Open Repair of a True Aneurysm of the Superior Mesenteric Artery.

JACC. Case reports
2025

The Emerging Role of Filamin A and FLNA Gene in Central Nervous System Functions: Insights into Neurodevelopment and Disease.

Journal of integrative neuroscience
2025

Decoding clinical diversity in monogenic TGFBR1 and TGFBR2 mutations: insights into the interplay of molecular mechanisms and hypomorphicity.

Frontiers in cell and developmental biology
2025

Prevalence of obstructive sleep apnea and related oropharyngeal symptoms in pediatric Ehlers Danlos patients.

International journal of pediatric otorhinolaryngology
2025

COL1-related overlap disorder: An emerging phenotype linked to mono- and bi-allelic COL1A1/2 variants.

Archives of oral biology
2025

A qualitative investigation of Ehlers-Danlos syndrome genetics triage.

Journal of genetic counseling
Ver todos os 3.240 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Síndrome Ehlers-Danlos.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Síndrome Ehlers-Danlos

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Children and adolescents with disorders of gut-brain interaction with comorbid hypermobility and orthostatic intolerance have worse outcomes.
    Journal of pediatric gastroenterology and nutrition· 2026· PMID 41858089mais citado
  2. Spontaneous coronary artery dissection and vascular Ehlers-Danlos syndrome: a systematic review and case series.
    European journal of human genetics : EJHG· 2026· PMID 41845085mais citado
  3. Generation of an induced pluripotent stem cell and isogenic control line from a vascular Ehlers-Danlos Syndrome (vEDS) patient harboring a pathogenic c.755G&gt;T in the COL3A1 gene.
    Stem cell research· 2026· PMID 41747624mais citado
  4. Prevalence of Intracranial and Cervical Artery Abnormalities in Patients with Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders Presenting to an Academic Headache Clinic.
    Neurology international· 2026· PMID 41745718mais citado
  5. Shared autonomic phenotype of long COVID and myalgic encephalomyelitis/chronic fatigue syndrome.
    PloS one· 2026· PMID 41576003mais citado
  6. Females with hypermobile Ehlers-Danlos syndrome self-report more sexual problems than chronic pain controls without hypermobility, males, or patients with hypermobile spectrum disorders.
    Front Reprod Health· 2026· PMID 41993759recente
  7. A safe seal: controlled flow arrest with dual balloon protection for embolisation of a large spontaneous splenic arteriovenous fistula-a case report.
    CVIR Endovasc· 2026· PMID 41989736recente
  8. The prevalence of dysautonomia in chronic musculoskeletal pain: a systematic review and meta-analysis.
    Rheumatol Adv Pract· 2026· PMID 41978692recente
  9. Tourniquet Use and Anesthesiology Considerations in Patients With Hypermobile Ehlers-Danlos Syndrome: Balancing Orthopedic Needs With Anesthetic Safety.
    Cureus· 2026· PMID 41978595recente
  10. Spectrum of Respiratory Involvement in Ehlers-Danlos Syndrome: Insights From a Case Report.
    Open Respir Arch· 2026· PMID 41971414recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:98249(Orphanet)
  2. MONDO:0020066(MONDO)
  3. GARD:6322(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Artigo Wikipedia(Wikipedia)
  7. Q1141499(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Síndrome Ehlers-Danlos
Compêndio · Raras BR

Síndrome Ehlers-Danlos

ORPHA:98249 · MONDO:0020066
Prevalência
Unknown
Herança
Autosomal dominant, Autosomal recessive, X-linked recessive
CID-10
Q79.6 · Síndrome de Ehlers-Danlos
CID-11
Ensaios
26 ativos
Início
Infancy, Neonatal
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C0013720
Repurposing
1 candidato
celiprololadrenergic receptor antagonist
EuropePMC
Wikidata
Wikipedia
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades